Strategies in the Global Tumor Marker Testing Market 2015
DUBLIN, May 29, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/pm4jtm/2015_strategies) has announced the addition of the "2015 Strategies in the Global Tumor Marker Testing Market: US, Europe, Japan" report to their offering.
Identifies and evaluates major business opportunities emerging in the tumor marker market during the next five yearsExamines trends in the U.S., Europe and JapanReviews current and emerging tumor markersAnalyzes applications of emerging diagnostic technologiesForecasts sales of major tumor markers by country and market segmentProfiles leading market players and potential entrants
Companies Mentioned:
- Abbott
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid
- Correlogic Systems/Vermillion
- Decode
- Diadexus
- Diagnocure
- Enzo Biochem
- Guided Therapeutics
- Hologic/Gen-Probe
- Kreatech
- Kyowa Medex
- Mackay Life Sciences
- Myriad Genetics
- PreMD
- Qiagen/Ipsogen
- Quest Diagnostics
- Radient Pharmaceuticals
- Roche
- Sequenom
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics & Therapeutics
- Tosoh
- Thermo Fisher/Life Technologies
- Veridex
- Wako Pure Chemicals
- Wallac/PE
- Zila
For more information visit http://www.researchandmarkets.com/research/pm4jtm/2015_strategies
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
Share this article